CAMP4 Therapeutics (CAMP) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	94.71M
Accounts receivable, less allowance for doubtful accounts of $258 and $290 at August 31, 2011 and February 28, 2011, respectively	68.77M
Inventories	28M
Costs and estimated earnings in excess of billings on uncompleted contracts
Deferred income tax assets
Prepaid expenses and other current assets	7.31M
Total current assets	221.08M
Property, equipment and improvements, net of accumulated depreciation and amortization	21.6M
Deferred income tax assets, less current portion	28.6M
Intangible assets, net
Other assets	10.78M
Assets, Total	420.16M
Bank working capital line of credit
Current portion of long-term debt
Accounts payable	36.6M
Accrued payroll and employee benefits	10.8M
Deferred revenue	16.86M
Other current liabilities	17.95M
Total current liabilities	82.2M
Long-term debt	143.26M
Other non-current liabilities	13.5M
Commitments and contingencies	0
Preferred stock, $.01 par value; 3,000 shares authorized; no shares issued or outstanding	0
Common stock, $.01 par value; 40,000 shares authorized; 28,702 and 28,147 shares issued and outstanding at August 31, 2011 and February 28, 2011, respectively	364K
Additional paid-in capital	223.68M
Accumulated deficit	-41.99M
Accumulated other comprehensive loss	-858K
Total stockholders' equity	181.2M
Liabilities and Equity, Total	420.16M

Entities mentioned with CAMP

View All Entities